Tredje AP fonden Cuts Stake in Danaher Corporation (DHR)

Tredje AP fonden reduced its position in Danaher Corporation (NYSE:DHR) by 8.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 123,873 shares of the conglomerate’s stock after selling 11,128 shares during the quarter. Tredje AP fonden’s holdings in Danaher were worth $10,643,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. National Asset Management Inc. lifted its stake in shares of Danaher by 0.4% in the 2nd quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock valued at $318,000 after acquiring an additional 14 shares during the last quarter. First Financial Corp IN raised its position in Danaher by 0.8% during the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after purchasing an additional 21 shares during the last quarter. Brighton Jones LLC raised its position in Danaher by 0.4% during the 2nd quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock valued at $435,000 after purchasing an additional 21 shares during the last quarter. Buckingham Asset Management LLC raised its position in Danaher by 0.4% during the 2nd quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock valued at $488,000 after purchasing an additional 24 shares during the last quarter. Finally, Simmons Bank raised its position in Danaher by 0.4% during the 2nd quarter. Simmons Bank now owns 7,160 shares of the conglomerate’s stock valued at $604,000 after purchasing an additional 26 shares during the last quarter. Hedge funds and other institutional investors own 76.32% of the company’s stock.

Danaher Corporation (DHR) traded down $0.21 during mid-day trading on Thursday, hitting $92.53. The company’s stock had a trading volume of 2,038,300 shares, compared to its average volume of 2,630,318. Danaher Corporation has a 1 year low of $76.27 and a 1 year high of $94.82. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. The stock has a market cap of $64,510.42, a P/E ratio of 23.84, a price-to-earnings-growth ratio of 2.21 and a beta of 1.02.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The firm had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same quarter in the prior year, the business earned $0.87 EPS. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. research analysts forecast that Danaher Corporation will post 3.99 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.61%. Danaher’s payout ratio is currently 16.52%.

In related news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction that occurred on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total value of $960,693.96. Following the sale, the director now owns 104,621 shares in the company, valued at approximately $9,501,679.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the sale, the chief executive officer now owns 271,737 shares in the company, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock worth $25,218,813 in the last 90 days. 12.20% of the stock is currently owned by company insiders.

A number of research analysts have commented on DHR shares. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research report on Thursday, October 5th. Cowen reaffirmed a “buy” rating and set a $90.00 price target on shares of Danaher in a research report on Wednesday, October 4th. Goldman Sachs Group reaffirmed a “neutral” rating and set a $83.00 price target on shares of Danaher in a research report on Tuesday, September 26th. Robert W. Baird upped their price target on Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Finally, Credit Suisse Group upped their price target on Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $93.31.

TRADEMARK VIOLATION WARNING: This story was reported by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3079666/tredje-ap-fonden-cuts-stake-in-danaher-corporation-dhr.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.